List of Tables
Table 1. Cancer Biopharmaceuticals Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Biopharmaceuticals Revenue
Table 3. Ranking of Global Top Cancer Biopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biologics
Table 6. Key Players of Biosimilars
Table 7. Global Cancer Biopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Cancer Biopharmaceuticals Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Cancer Biopharmaceuticals Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Cancer Biopharmaceuticals Market Share by Regions (2015-2020)
Table 11. Global Cancer Biopharmaceuticals Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Cancer Biopharmaceuticals Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Cancer Biopharmaceuticals Market Growth Strategy
Table 17. Main Points Interviewed from Key Cancer Biopharmaceuticals Players
Table 18. Global Cancer Biopharmaceuticals Revenue by Players (2015-2020) (Million US$)
Table 19. Global Cancer Biopharmaceuticals Market Share by Players (2015-2020)
Table 20. Global Top Cancer Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopharmaceuticals as of 2019)
Table 21. Global Cancer Biopharmaceuticals by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Biopharmaceuticals Product Solution and Service
Table 24. Date of Enter into Cancer Biopharmaceuticals Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 27. Global Cancer Biopharmaceuticals Market Size Share by Type (2015-2020)
Table 28. Global Cancer Biopharmaceuticals Revenue Market Share by Type (2021-2026)
Table 29. Global Cancer Biopharmaceuticals Market Size Share by Application (2015-2020)
Table 30. Global Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 31. Global Cancer Biopharmaceuticals Market Size Share by Application (2021-2026)
Table 32. North America Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 34. North America Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 35. North America Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 36. North America Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 37. North America Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 38. Europe Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 40. Europe Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 42. Europe Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 44. China Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 45. China Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 46. China Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 47. China Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 48. China Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 49. China Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 50. Japan Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 52. Japan Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 54. Japan Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 58. Southeast Asia Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 60. Southeast Asia Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 62. India Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 63. India Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 64. India Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 65. India Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 66. India Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 67. India Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Cancer Biopharmaceuticals Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Cancer Biopharmaceuticals Market Share (2019-2020)
Table 70. Central & South America Cancer Biopharmaceuticals Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Cancer Biopharmaceuticals Market Share by Type (2015-2020)
Table 72. Central & South America Cancer Biopharmaceuticals Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Cancer Biopharmaceuticals Market Share by Application (2015-2020)
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Product
Table 77. Sanofi Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 78. Sanofi Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Product
Table 82. Johnson & Johnson Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 83. Johnson & Johnson Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Product
Table 87. Pfizer Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 88. Pfizer Recent Development
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Product
Table 92. Novartis Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 93. Novartis Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. GlaxoSmithKline Company Details
Table 100. GlaxoSmithKline Business Overview
Table 101. GlaxoSmithKline Product
Table 102. GlaxoSmithKline Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 103. GlaxoSmithKline Recent Development
Table 104. Eli Lilly Company Details
Table 105. Eli Lilly Business Overview
Table 106. Eli Lilly Product
Table 107. Eli Lilly Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 108. Eli Lilly Recent Development
Table 109. Agios Pharmaceuticals Business Overview
Table 110. Agios Pharmaceuticals Product
Table 111. Agios Pharmaceuticals Company Details
Table 112. Agios Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 113. Agios Pharmaceuticals Recent Development
Table 114. Bristol-Myers Squibb Company Details
Table 115. Bristol-Myers Squibb Business Overview
Table 116. Bristol-Myers Squibb Product
Table 117. Bristol-Myers Squibb Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 118. Bristol-Myers Squibb Recent Development
Table 119. AstraZeneca Company Details
Table 120. AstraZeneca Business Overview
Table 121. AstraZeneca Product
Table 122. AstraZeneca Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 123. AstraZeneca Recent Development
Table 124. Mylan Company Details
Table 125. Mylan Business Overview
Table 126. Mylan Product
Table 127. Mylan Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 128. Mylan Recent Development
Table 129. LEO Pharma Company Details
Table 130. LEO Pharma Business Overview
Table 131. LEO Pharma Product
Table 132. LEO Pharma Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 133. LEO Pharma Recent Development
Table 134. Boehringer Ingelheim Company Details
Table 135. Boehringer Ingelheim Business Overview
Table 136. Boehringer Ingelheim Product
Table 137. Boehringer Ingelheim Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 138. Boehringer Ingelheim Recent Development
Table 139. Alexion Pharmaceuticals Company Details
Table 140. Alexion Pharmaceuticals Business Overview
Table 141. Alexion Pharmaceuticals Product
Table 142. Alexion Pharmaceuticals Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 143. Alexion Pharmaceuticals Recent Development
Table 144. Elusys Therapeutics Company Details
Table 145. Elusys Therapeutics Business Overview
Table 146. Elusys Therapeutics Product
Table 147. Elusys Therapeutics Revenue in Cancer Biopharmaceuticals Business (2015-2020) (Million US$)
Table 148. Elusys Therapeutics Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biopharmaceuticals Market Share by Type: 2020 VS 2026
Figure 2. Biologics Features
Figure 3. Biosimilars Features
Figure 4. Global Cancer Biopharmaceuticals Market Share by Application: 2020 VS 2026
Figure 5. Liquid Cancers Case Studies
Figure 6. Solid Cancers Case Studies
Figure 7. Cancer Biopharmaceuticals Report Years Considered
Figure 8. Global Cancer Biopharmaceuticals Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Cancer Biopharmaceuticals Market Share by Regions: 2020 VS 2026
Figure 10. Global Cancer Biopharmaceuticals Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Cancer Biopharmaceuticals Market Share by Players in 2019
Figure 13. Global Top Cancer Biopharmaceuticals Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopharmaceuticals as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Cancer Biopharmaceuticals Revenue in 2019
Figure 15. North America Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Cancer Biopharmaceuticals Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Sanofi Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 24. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Johnson & Johnson Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Pfizer Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 28. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Novartis Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 30. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Merck Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 32. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. GlaxoSmithKline Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 34. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Eli Lilly Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 36. Agios Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Agios Pharmaceuticals Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 38. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 40. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. AstraZeneca Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 42. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Mylan Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 44. LEO Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. LEO Pharma Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 46. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 48. Alexion Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Alexion Pharmaceuticals Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 50. Elusys Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Elusys Therapeutics Revenue Growth Rate in Cancer Biopharmaceuticals Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
